A treatment option for people with GIST

AYVAKIT™ (avapritinib): the first FDA-approved tyrosine kinase inhibitor for people with a gastrointestinal stromal tumor (GIST) who have a PDGFRA exon 18 mutation.

AYVAKIT selectively targets KIT and PDGFRA mutant kinases, the primary drivers of GIST.

YourBlueprint™ provides personalized support throughout treatment with AYVAKIT.

LEARN MORE DOWNLOAD PATIENT INFORMATION
 

What is AYVAKIT?

AYVAKIT is a prescription medicine used to treat adults with a certain type of stomach, bowel, or esophagus cancer called gastrointestinal stromal tumor (GIST) that cannot be treated with surgery or that has spread to other parts of the body (metastatic), and that is caused by certain abnormal platelet-derived growth factor receptor alpha (PDGFRA) genes.

  • Your healthcare provider will perform a test to make sure that you have this abnormal PDGFRA gene and that AYVAKIT is right for you

It is not known if AYVAKIT is safe and effective in children.

 

Support and Resources

Empower yourself with information by connecting with our support team or by reading more about AYVAKIT.

This brochure is intended for digital use only. If you decide to print it, please be sure to print and attach a copy of the full Prescribing Information as well.

HELPFUL RESOURCES FOR PEOPLE WITH GIST AND THEIR CAREGIVERS:

American Cancer Society* cancer.org 800-227-2345
National Cancer Institute* cancer.gov 800-422-6237
GIST Support International* gistsupport.org 215-340-9374
The Life Raft Group* liferaftgroup.org 973-837-9092
Mutation Matters mutationmatters.com

*Blueprint Medicines is not affiliated with these organizations, does not endorse any particular service or group, and is not responsible for the content on their websites or any services or resources they may provide.

YourBlueprint is a patient support program designed to assist you throughout your treatment with AYVAKIT by providing:

  • 1-on-1 support
  • Financial assistance options
  • Helpful resources

For more information, click below or call 1-888-BLUPRNT (1-888-258-7768) today.

Support is a click away
 

IMPORTANT SAFETY INFORMATION

AYVAKIT may cause serious side effects, including:

  • Bleeding in your brain. Stop taking AYVAKIT and tell your healthcare provider if you develop any symptoms such as severe headache, vision problems, severe sleepiness, or severe weakness on one side of your body.
  • Central nervous system (CNS) effects. CNS side effects are common with AYVAKIT and can be severe. Tell your healthcare provider if you develop any new or worsening CNS symptoms including forgetfulness, confusion, getting lost, trouble thinking, drowsiness, dizziness, trouble sleeping, word finding problems, seeing objects or hearing things that are not there (hallucinations), or change in mood or behavior.

Your healthcare provider may temporarily stop treatment or decrease your dose which may help your symptoms improve. If symptoms do not improve, your healthcare provider may permanently stop treatment with AYVAKIT.

Before taking AYVAKIT, tell your healthcare provider about all of your medical conditions, including if you:

  • are pregnant or plan to become pregnant. AYVAKIT can cause harm to your unborn baby.
    • Females who are able to become pregnant:

      • Your healthcare provider should do a pregnancy test before you start AYVAKIT.
      • You should use effective birth control (contraception) during treatment with AYVAKIT and for 6 weeks after the final dose of AYVAKIT. Talk to your healthcare provider about birth control methods that may be right for you.
      • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with AYVAKIT.
    • Males with female partners who are able to become pregnant should use effective birth control (contraception) during treatment and for 6 weeks after the final dose of AYVAKIT.

  • are breastfeeding or plan to breastfeed. It is not known if AYVAKIT passes into your breast milk. Do not breastfeed during treatment with AYVAKIT and for at least 2 weeks after the final dose of AYVAKIT. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. AYVAKIT may affect the way other medicines work, and certain other medicines may affect how AYVAKIT works. Talk to your healthcare provider prior to starting a new medicine.

What should I avoid while taking AYVAKIT?

Do not drive or operate hazardous machinery, if you have confusion or trouble thinking during treatment with AYVAKIT.

The most common side effects of AYVAKIT include:

  • fluid retention or swelling
  • nausea
  • tiredness
  • muscle weakness
  • vomiting
  • diarrhea
  • decreased appetite
  • stomach area (abdominal) pain
  • increased eye tearing
  • constipation
  • rash
  • dizziness, and
  • hair color changes

These are not all of the possible side effects of AYVAKIT. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see the full Prescribing Information and Patient Information for AYVAKIT.

WHAT IS AYVAKIT?

AYVAKIT is a prescription medicine used to treat adults with a certain type of stomach, bowel, or esophagus cancer called gastrointestinal stromal tumor (GIST) that cannot be treated with surgery or that has spread to other parts of the body (metastatic), and that is caused by certain abnormal platelet-derived growth factor receptor alpha (PDGFRA) genes

  • Your healthcare provider will perform a test to make sure that you have this abnormal PDGFRA gene and that AYVAKIT is right for you.
It is not known if AYVAKIT is safe and effective in children.

AYVAKIT, Blueprint Medicines, YourBlueprint and associated logos are trademarks of Blueprint Medicines Corporation.

© 2020 Blueprint Medicines Corporation. This site is intended for U.S. audiences only.

07/2020     USBP-PRA-19.021.2

You are about to leave AYVAKIT.com.

Blueprint Medicines is not responsible for any information, statements, or other content you may encounter on third-party websites.